AJJARAPU SURENDRA K 4

What Happened
Ajjarapu Surendra K, a director of Wellgistics Health, exercised in‑the‑money derivatives/warrants on June 22, 2026, acquiring a total of 200,000 shares. The filing shows two exercises: 100,000 shares at $0.01 ($500 cash) and 100,000 shares at $0.00 (no cash). These shares were obtained via conversion of warrants issued to the reporting person on March 31, 2026, in lieu of cash compensation. No sale of the shares was reported in the Form 4.

Key Details

• Transaction date: 2026-06-22. Filing date: 2026-06-25 (three days later). Form 4s are generally due within two business days—review the filing for any late-reporting notation.
• Specifics: 100,000 shares acquired at $0.01 (total $500); 100,000 shares acquired at $0.00 (total $0). Aggregate = 200,000 shares for $500.
• Footnote F1: Warrants issued 3/31/2026 were converted in lieu of cash compensation.
• Footnote F2: Post-transaction holdings were adjusted to reflect the issuer’s reverse stock split effective May 26, 2026, plus shares from the warrant conversion — see the Form 4 for the exact post‑transaction share total.
• No indication in the provided data that shares were immediately sold (i.e., not a cashless exercise followed by a sale).

Context
This was an exercise/conversion of warrants (derivative securities) rather than an open‑market purchase or sale. Conversions issued in lieu of compensation are common corporate practices and do not, by themselves, indicate the insider is buying or selling for investment reasons. For precise holdings and any late‑filing consequences, consult the full Form 4 (Accession No. 0001493152-26-030154).